Publications:

Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers.

Molecular Cancer Therapeutics

Sakamuri, Divya D; Glitza, Isabella C IC; Betancourt Cuellar, Sonia L SL; Subbiah, Vivek V; Fu, Siqing S; Tsimberidou, Apostolia M AM; Wheler, Jennifer J JJ; Hong, David S DS; Naing, Aung A; Falchook, Gerald S GS; Fanale, Michelle A MA; Cabanillas, Maria E ME; Janku, Filip F

Publication Date: 2018-03

Variant appearance in text: RB1: E50*

PubMed Link: 29237802

Variant Present in the following documents:

• Main text

View BVdb publication page

Alterations in the RB1 gene in Pakistani patients with retinoblastoma using direct sequencing analysis.

Molecular Vision

Kalsoom, Saeeda S; Wasim, Muhammad M; Afzal, Sibtain S; Shahzad, Muhammad Saqib MS; Ramzan, Shaiqa S; Awan, Ali Raza AR; Anjum, Aftab Ahmed AA; Ramzan, Khushnooda K

Publication Date: 2015

Variant appearance in text: RB1: 148G>T; Glu50*

PubMed Link: 26396485

Variant Present in the following documents:

• Main text
• mv-v21-1085.pdf

View BVdb publication page